Avalon GloboCare Corp. (ALBT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avalon GloboCare Corp. (ALBT) has a cash flow conversion efficiency ratio of -0.264x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.09 Million) by net assets ($11.72 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Avalon GloboCare Corp. (ALBT) balance sheet quality index to measure how much of total assets are equity-financed.
Avalon GloboCare Corp. - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Avalon GloboCare Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Avalon GloboCare Corp. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Avalon GloboCare Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avalon GloboCare Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Magnetite Mines Ltd
AU:MGT
|
-0.030x |
|
Nanocap Group AB Series B
ST:NANOC-B
|
N/A |
|
International Prospect Ventures Ltd
V:IZZ
|
-0.357x |
|
Maison Solutions Inc
NASDAQ:MSS
|
0.205x |
|
Sparton Resources Inc
V:SRI
|
-0.143x |
|
Antler Gold Inc
V:ANTL
|
0.002x |
|
METCH INTL LTD. SD -25
F:VZ3P
|
N/A |
|
Azincourt Uranium Inc
V:AAZ
|
-0.089x |
Annual Cash Flow Conversion Efficiency for Avalon GloboCare Corp. (2015–2025)
The table below shows the annual cash flow conversion efficiency of Avalon GloboCare Corp. from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Avalon GloboCare Corp. worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $9.23 Million | $-4.99 Million | -0.540x | +22.76% |
| 2024-12-31 | $7.10 Million | $-4.97 Million | -0.700x | +20.74% |
| 2023-12-31 | $7.37 Million | $-6.50 Million | -0.883x | -39.98% |
| 2022-12-31 | $11.16 Million | $-7.04 Million | -0.631x | +61.29% |
| 2021-12-31 | $3.08 Million | $-5.02 Million | -1.629x | +11.13% |
| 2020-12-31 | $4.12 Million | $-7.55 Million | -1.833x | -15.60% |
| 2019-12-31 | $4.47 Million | $-7.08 Million | -1.586x | -305.92% |
| 2018-12-31 | $11.25 Million | $-4.40 Million | -0.391x | -113.11% |
| 2017-12-31 | $7.31 Million | $-1.34 Million | -0.183x | -4748.22% |
| 2016-12-31 | $3.55 Million | $13.98K | 0.004x | -99.93% |
| 2015-12-31 | $-5.41K | $-30.11K | 5.569x | -- |
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI … Read more